Allelic variation in the size of the insulin (INS) variable number tandem r
epeat (VNTR) correlates with the expression of both INS in the pancreas and
thymus and IGF2 (the gene downstream of INS) in the placenta. In addition,
the shorter, class I alleles are associated with type 1 diabetes, whereas
the longer, class III alleles are associated with type 2 diabetes, polycyst
ic ovary syndrome (PCOS), and size at birth. Parent-of-origin effects have
been reported for type 2 diabetes and PCOS, thus implicating a role for gen
omic imprinting in these phenotypes. In mice, Ins2 is imprinted and paterna
lly expressed in the yolk sec. In humans, evidence for the imprinting of IN
S is circumstantial, with occasional monoallelic expression in the thymus.
In the present study, we found evidence for the imprinted paternal expressi
on of INS in the human yolk sec. Two other imprinted genes from the same cl
uster are also expressed monoallelically in the human yolk sac. IGF2 was ex
pressed solely from the paternal allele, and H19 was expressed solely from
the maternal allele. These data suggest not only further functional roles f
or the human yolk sac in early fetal growth, but also evidence for a potent
ial causal link between the control of insulin expression during developmen
t and insulin/growth-related diseases in later life.